These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16678073)

  • 1. Genetics of hepatobiliary diseases.
    Juran BD; Lazaridis KN
    Clin Gastroenterol Hepatol; 2006 May; 4(5):548-57. PubMed ID: 16678073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomics and complex liver disease: Challenges and opportunities.
    Juran BD; Lazaridis KN
    Hepatology; 2006 Dec; 44(6):1380-90. PubMed ID: 17133459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying genomics to the study of complex disease.
    Juran BD; Lazaridis KN
    Semin Liver Dis; 2007 Feb; 27(1):3-12. PubMed ID: 17295173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis of inherited disorders of the gastrointestinal and hepatobiliary tracts. An update on recent progress.
    Martín MG; Turk E
    Gastroenterol Clin North Am; 1995 Mar; 24(1):45-70. PubMed ID: 7729861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetics of alcoholic liver disease: better patient group definition is required.
    Nguyen-Khac E; Houchi H; Daoust M; Naassïla M
    Am J Gastroenterol; 2009 Jul; 104(7):1848-9; author reply 1849. PubMed ID: 19574978
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholestatic liver disease.
    Jüngst C; Lammert F
    Dig Dis; 2013; 31(1):152-4. PubMed ID: 23797137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-based prediction of common diseases: advances and prospects.
    Janssens AC; van Duijn CM
    Hum Mol Genet; 2008 Oct; 17(R2):R166-73. PubMed ID: 18852206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of biliary tract diseases: new insights into gallstone disease and biliary tract cancers.
    Höblinger A; Lammert F
    Curr Opin Gastroenterol; 2008 May; 24(3):363-71. PubMed ID: 18408466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases.
    Wu TT; Levy M; Correa AM; Rosen CB; Abraham SC
    Cancer; 2009 Oct; 115(19):4564-75. PubMed ID: 19670455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human genetic diversity and the epidemiology of parasitic and other transmissible diseases.
    Tibayrenc M
    Adv Parasitol; 2007; 64():377-422. PubMed ID: 17499103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the transforming growth factor beta1 codon 25 (Arg-->Pro) polymorphism in alcoholic liver disease.
    Osterreicher CH; Halangk J; Berg T; Patsenker E; Homann N; Hellerbrand C; Seitz HK; Eurich D; Stickel F
    Cytokine; 2008 Apr; 42(1):18-23. PubMed ID: 18337117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of genomic and proteomic technologies in predictive, preventive and personalized medicine.
    Collins CD; Purohit S; Podolsky RH; Zhao HS; Schatz D; Eckenrode SE; Yang P; Hopkins D; Muir A; Hoffman M; McIndoe RA; Rewers M; She JX
    Vascul Pharmacol; 2006 Nov; 45(5):258-67. PubMed ID: 17030152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatobiliary disease in patients with cystic fibrosis.
    Moyer K; Balistreri W
    Curr Opin Gastroenterol; 2009 May; 25(3):272-8. PubMed ID: 19381084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of molecular defects in liver diseases. Recent advances].
    Arrese M
    Rev Med Chil; 1999 Sep; 127(9):1112-20. PubMed ID: 10752277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental genomics: a key to understanding biology, pathophysiology and disease.
    Schwartz DA; Freedman JH; Linney EA
    Hum Mol Genet; 2004 Oct; 13 Spec No 2():R217-24. PubMed ID: 15358728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of endotoxin receptor CD14 and TLR4 gene variants in chronic liver disease.
    Von Hahn T; Halangk J; Witt H; Neumann K; Müller T; Puhl G; Neuhaus P; Nickel R; Beuers U; Wiedenmann B; Berg T
    Scand J Gastroenterol; 2008; 43(5):584-92. PubMed ID: 18415752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evidence of maternal microchimerism in biliary atresia using fluorescent in situ hybridization.
    Hayashida M; Nishimoto Y; Matsuura T; Takahashi Y; Kohashi K; Souzaki R; Taguchi T
    J Pediatr Surg; 2007 Dec; 42(12):2097-101. PubMed ID: 18082716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam.
    Toan NL; Song le H; Kremsner PG; Duy DN; Binh VQ; Koeberlein B; Kaiser S; Kandolf R; Torresi J; Bock CT
    Hepatology; 2006 Jun; 43(6):1375-84. PubMed ID: 16729315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of disease: the genetic epidemiology of gallbladder stones.
    Lammert F; Sauerbruch T
    Nat Clin Pract Gastroenterol Hepatol; 2005 Sep; 2(9):423-33. PubMed ID: 16265433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism in cytochrome P450 2E1 and interaction with other genetic risk factors and susceptibility to alcoholic liver cirrhosis.
    Khan AJ; Ruwali M; Choudhuri G; Mathur N; Husain Q; Parmar D
    Mutat Res; 2009 May; 664(1-2):55-63. PubMed ID: 19428381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.